Clinical trials
Phase 2 Rhinitis, Allergic, Seasonal trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 2 |
| 2006 | 7 |
| 2007 | 9 |
| 2008 | 11 |
| 2009 | 8 |
| 2010 | 6 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 8 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 77 |
| Recruiting | 3 |
| Unknown status | 3 |
| Terminated | 2 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 7 |
| Laboratorios Leti, S.L. | 4 |
| Bausch & Lomb Incorporated | 3 |
| BioTech Tools S.A. | 3 |
| Capnia, Inc. | 3 |
| Circassia Limited | 3 |
| Faes Farma, S.A. | 3 |
| Merck Sharp & Dohme LLC | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rhinitis, Allergic, Seasonal | 89 |
| Rhinitis, Allergic | 17 |
| Hypersensitivity | 14 |
| Rhinitis | 9 |
| Conjunctivitis, Allergic | 6 |
| Asthma | 5 |
| Sneezing | 3 |
| Rhinorrhea | 2 |
| Food Hypersensitivity | 1 |
| Immune System Diseases | 1 |
Trials
Showing 76 to 89 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.